The Indian government on January 16 launched the biggest vaccine drive to prevent the corona virus epidemic in the country. Let us tell you that Corona virus, which took the form of epidemic last year, has killed about 1.5 lakh people in India so far.
The vaccination drive started on January 16 with doctors using the vaccine – Covishield, made by Serum Institute of India, and Covaxin, created by Bharat Biotech. However, within a few days of the vaccine program being launched, Bharat Biotech has released its Fact Sheet, which along with the entire process, tells who should not get the vaccine.
According to the Fact Sheet of the website of Bharat Biotech, if a person is on any kind of allergy, fever, bleeding disorder or blood thinning medicine, then one should not take the Covid-19 vaccine ‘Covaxin’. It also states that pregnant and lactating women should also avoid taking Covaxin.
The company said, people who have poor immunity, or are on drugs that affect the immune system, and those who have been given another Covid-19 vaccine, should not get the Bharat Biotech vaccine.
Who should get Covaxin shots?
The Central Drugs Standard Control Organization (CDSCO) has authorised the restricted emergency use of Bharat Biotech-made Covaxin vaccine against coronavirus infection. This means that all individuals who are prioritized under the government’s vaccine program and without the aforementioned medical conditions can take the Covaxin jab.
India’s coronavirus vaccination program, deemed as the world’s largest inoculation drive, began on Saturday, January 16, 2021. While Oxford-AstraZeneca’s Covishield is being manufactured by the Serum Institute of India, Covaxin is being produced by Bharat Biotech.
In the first phase, the vaccines are being administered to frontline health workers across the country.
WHAT ARE THE INGREDIENTS IN THE BHARAT BIOTECH COVID-19
VACCINE (COVAXIN ?
The BHARAT BIOTECH COVID-19 VACCINE ‘COVAXIN’, includes the following
ingredients: COVAXIN,…contains 611g of whole-virion inactivated SARS-CoV-2 antigen (Strain: NIV-2020-770), and the other inactive ingredients such as aluminum hydroxide gel
(250 Jg), TLR 7/8 agonist (imidazoquinolinone) 15 Jlg, 2-phenoxyethanol 2.5 mg, and phosphate buffer saline up to 0.5 mi. The vaccine ‘COVAXIN’ has been developed by using inactivated/killed virus along with the aforementioned chemicals.